Increased Collagen IV Excretion in Diabetes

Abstract

OBJECTIVE—Increased albumin excretion in diabetes is believed to be derived from hemodynamic and/or permeability abnormalities, whereas mesangial matrix expansion gives rise to the reduction in glomerular filtration surface and decline in renal function in diabetic nephropathy. We postulated that the overproduction of extracellular matrix proteins underlying glomerulosclerosis in diabetes might be associated with the excretion of increased amounts of type IV collagen in the urine. RESEARCH DESIGN AND METHODS—To explore this hypothesis, we measured the urinary excretion of (human) collagen IV by immunoassay in 65 patients with type 1 or type 2 diabetes and various degrees of albuminuria and examined its relationship to filtration function assessed by the reciprocal of the serum creatinine (RSC). RESULTS—Collagen IV excretion showed a significant (P < 0.001) inverse correlation (r = −0.62) with the RSC, and this correlation pertained regardless of whether albumin excretion was in the low (≤100 μg/mg creatinine; r = −0.73) or high (>100 μg/mg; r = −0.53) range. In contrast, albumin excretion showed insignificant correlation with either collagen IV excretion (r = 0.12) or with the RSC (r = −0.20). Urinary collagen IV was significantly higher (P < 0.05) in patients with an RSC value ≤100 (28.3 ± 2.4 ng/mg creatinine) than in patients with an RSC value >100 (16.0 ± 0.8 ng/mg creatinine). CONCLUSIONS—Because not all patients with microalbuminuria progress to declining renal function and some patients who develop nephropathy do not manifest albuminuria, the findings in this cross-sectional analysis suggest that measurement of urine collagen IV may be a useful noninvasive indicator to detect diabetic renal disease entering a phase of compromised renal function.